Mitigating the Need for Peptide Production with Small Molecule GLP-1 Receptor Agonists: Balancing Pharmacokinetics with Efficacy
Time: 3:40 pm
day: Conference Day One
Details:
- Exploring the benefits of small molecule GLP-1 receptor agonists over injectable peptide-based therapeutics
- Navigating differential efficacy and safety profiles compared to peptide-based therapeutics from biological stability to receptor selectivity
- Exploring the differential pharmacokinetic profile and key considerations for development
